Showing 361 - 380 results of 128,498 for search '(( i e decrease ) OR ( 5 ((((non decrease) OR (point decrease))) OR (a decrease)) ))', query time: 1.90s Refine Results
  1. 361
  2. 362
  3. 363

    Api5 depletion induces a decrease in E2F1-target gene mRNA levels without affecting E2F1 expression. by Marina Garcia-Jove Navarro (442768)

    Published 2013
    “…<p><b>A.</b> Api5 and E2F1 reciprocal regulation. After depletion of Api5 and E2F1 with specific siRNAs, H1299 cells were made quiescent by serum starvation for 48 h (0% FBS) and then allowed to progress through the cell cycle over 10 hours by FBS addition (10 h refeeding). …”
  4. 364
  5. 365

    Decreased BIRC6 expression induces apoptosis and inhibits autophagosome formation. by Christopher G. Low (280918)

    Published 2013
    “…<p><b>A</b>, apoptosis of LNCap cells transfected with Lipofectamine (Lipo), non-targeting control siRNA (NT) or <i>BIRC6</i> siRNA2 and subsequently incubated for 48 h, as assessed by flow cytometric analysis of Annexin V/PI stained cells. …”
  6. 366
  7. 367
  8. 368
  9. 369
  10. 370
  11. 371

    GRIP1<sup>-/-</sup> platelets do not have decreased velocity in ionophore-stimulated blood vessels. by Kristina L. Modjeski (3123072)

    Published 2016
    “…E) GRIP1<sup>-/-</sup> platelets have a trend toward reduced vWF adhesion in vitro. …”
  12. 372

    Modeling micro-injuries by introducing a certain percent (1%, or 10%, or 20%) decrease in the number of differentiated cells in 0.01% of temporal updates (randomly chosen). by Jienian Yang (839934)

    Published 2016
    “…In (a), most divisions are asymmetric (<i>S</i> = 0.1), and in (b), all divisions are symmetric (<i>S</i> = 1). …”
  13. 373
  14. 374
  15. 375

    Image5_Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma via decreasing infiltrating T‐lymphocytes: A bioinformatic analysis.TIF by Runzhi Huang (7428713)

    Published 2022
    “…Meanwhile, enhancers transcript non-coding RNAs, known as enhancer RNAs (eRNAs), which may serve as potential diagnosis markers and therapeutic targets in Ewing sarcoma.…”
  16. 376
  17. 377
  18. 378
  19. 379
  20. 380